Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

GM Helix Implant,Ti,4.0X16: medical device reports filed with FDA

1,529 reports name it, 2020–2026. Manufacturer given most often on reports: Jjgc. Product code DZE.

1,529
device reports naming the brand
0% of all MAUDE reports · about 242 a year
669
reports, 12 months to August 2026
381 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 1,529 reports that name the brand "GM Helix Implant,Ti,4.0X16" (endosseous dental implant), received between March 2020 and August 2026; the manufacturer given most often on reports is Jjgc. Spellings of one product vary from report to report.

669 reports arrived in the 12 months to August 2026, up 76% from 381 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (78%), loss of osseointegration (9.5%) and difficult to insert (2.9%). The patient problems coded most often are pain, fibrosis and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

04590Sep 2021: 4Oct 2021: 4Nov 2021: 6Dec 2021: 22022Jan 2022: 0Feb 2022: 2Mar 2022: 18Apr 2022: 6May 2022: 7Jun 2022: 9Jul 2022: 3Aug 2022: 6Sep 2022: 13Oct 2022: 8Nov 2022: 8Dec 2022: 52023Jan 2023: 13Feb 2023: 10Mar 2023: 20Apr 2023: 12May 2023: 11Jun 2023: 27Jul 2023: 11Aug 2023: 15Sep 2023: 17Oct 2023: 23Nov 2023: 28Dec 2023: 122024Jan 2024: 12Feb 2024: 7Mar 2024: 11Apr 2024: 23May 2024: 35Jun 2024: 10Jul 2024: 18Aug 2024: 36Sep 2024: 44Oct 2024: 22Nov 2024: 31Dec 2024: 232025Jan 2025: 17Feb 2025: 30Mar 2025: 28Apr 2025: 23May 2025: 0Jun 2025: 90Jul 2025: 34Aug 2025: 39Sep 2025: 58Oct 2025: 38Nov 2025: 59Dec 2025: 692026Jan 2026: 37Feb 2026: 50Mar 2026: 47Apr 2026: 56May 2026: 61Jun 2026: 64Jul 2026: 63Aug 2026: 67

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

02434852020: 1120202021: 3220212022: 8520222023: 19920232024: 27220242025: 48520252026: 4452026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%1,529
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report87.7%1,341
Voluntary report0%0
User facility report0%0
Distributor report12.3%188
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate1,19278%62.8%
Loss of osseointegration1469.5%22.4%
Difficult to insertthe device was hard to insert442.9%0.4%
Fracturea broken bone60.4%1.6%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Painpain, site not specified33722%
Fibrosis30519.9%
Inflammationinflammation996.5%
Swelling/ edema905.9%
Hemorrhage/blood loss/bleeding614%
Abscessa collection of pus342.2%
Fistula342.2%
Hyperresponsive to stimuli171.1%
Numbnessnumbness100.7%
Hypersensitivity/allergic reaction60.4%
Sinus perforation40.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureGM Helix Implant,Ti,4.0X16Product code DZEAll MAUDE reports
Reports1,5293,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer87.7%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about GM Helix Implant,Ti,4.0X16 reports

How many FDA reports name GM Helix Implant,Ti,4.0X16?

1,529 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 669 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (78%), loss of osseointegration (9.5%), difficult to insert (2.9%) and fracture (0.4%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (87.7%) and distributor reports (12.3%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that GM Helix Implant,Ti,4.0X16 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.